In 2025, Espromed Bio in Venezuela will start insulin production using Russian technology from Geropharm. Russian Deputy Prime Minister Dmitry Chernyshenko announced the final plant preparations. Total investments include 5.5 million euros for modernization and 16 million euros for operating activities.
The plant has modernized production, with tests planned, and expects to register insulin preparations for Venezuelan patients by 2026. Geropharm will continue supplying the country with substances from its St. Petersburg plant and insulin analogues in cartridges.